tradingview
CHRS Q2'26 Earnings: revenue estimate is 14.41M USD
CHRS (Coherus Oncology, Inc.) is set to announce its Q2'26 results on July 30, time not specified. The earnings are expected to be disclosed at 8:00 AM ET (12:00 PM UTC).For Q2'26, revenue estimate is 14.41 million USD with EPS (earnings per share) anticipated at (0.24) USD. Learn more details at C…